Repeats [Study As­sess­ment]

posted by ElMaestro  – Denmark, 2013-07-27 13:31 (4307 d 07:25 ago) – Posting: # 11070
Views: 20,710

Hi Sam,

❝ The PE of my pilot study was 90% and based on that the sample size of 54 was considered and including the dropout and withdrawn the final sample size of 64 was considered. But in the pivotal study the PE comes out to be 79% with power of 100% which shows that our sample size is very correct but there is some problem may be with study conduct or formulation. We have one more justification that the Pivotal PE of the Fed study is same as that of the Pilot which we carried out and Fed study meets the BE criteria.


Post-hoc power is to me not meaningful. I have no idea how to apply knowledge of that value. And stop up and think: What can you say about the power of a trial in which your PE is close to 0.79 regardless of sample size etc.?

Honestly, I think might be game over for the current formulation unless you have a good reason to cast doubt over the result (and as indicated above, a good reason is not just that the result is unwanted). If the past result is credible then a repeat trial could very well be futile and thus unethical as well as a waste of time and money.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
58 visitors (0 registered, 58 guests [including 31 identified bots]).
Forum time: 20:56 CEST (Europe/Vienna)

If you shut your door to all errors
truth will be shut out.    Rabindranath Tagore

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5